Prosecution Insights
Last updated: April 19, 2026

Beyondspring Pharmaceuticals Inc.

5 pending office actions

Portfolio Summary

5
Total Pending OAs
1
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18952618 USE OF PLINABULIN IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS SAJJADI, FEREYDOUN GHOTB 1699 Final Rejection Nov 19, 2024
18837546 STABLE PLINABULIN FORMULATIONS AND METHODS OF THEIR PREPARATION AND USE GODDARD, LAURA B 1642 Non-Final OA Aug 09, 2024
18671711 PLINABULIN COMPOSITIONS KIFLE, BRUCK 1624 Non-Final OA May 22, 2024
18554595 THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING TUMORS PECKHAM, RICHARD GRANT 1627 Non-Final OA Oct 09, 2023
17923189 TRIPLE COMBINATION THERAPY FOR ENHANCING CANCER CELL KILLING IN CANCERS WITH LOW IMMUNOGENICITY GODDARD, LAURA B 1642 Non-Final OA Nov 03, 2022

Managing Beyondspring Pharmaceuticals Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month